Next-Gen Cytogenetic Genomic Integrity Assays for C> Development
Time: 12:00 pm
day: Day 1- Manufacturing 1
Details:
- KROMATID’s single cell cytogenetic platform provides advanced characterization and data analysis of genomic integrity for gene modified cell therapies
- Nationwide Children’s CARNK novel allogeneic therapy utilized KROMATID’s platform to assist in characterizing the safety profile of their therapy for hematologic malignancies
- Cytogenetic testing provides critical orthogonal data for characterization of whole genome assessment of transgene integration and on-and-off target genotoxicity
